Free Trial
→ “Sell Nvidia before earnings” (From InvestorPlace) (Ad)tc pixel Free CTOR Stock Alerts

Citius Oncology (CTOR) SEC Filings & 10K Form

Citius Oncology logo
$1.88 +0.01 (+0.53%)
Closing price 04:00 PM Eastern
Extended Trading
$1.90 +0.02 (+0.80%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Citius Oncology SEC Filings

Export to Excel
DateFilerForm TypeView
09/04/2025
11:15 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form EFFECT
09/02/2025
7:00 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/12/2025
3:45 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2025
7:01 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2025
8:21 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 424B4
07/16/2025
11:15 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form EFFECT
07/14/2025
4:22 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form S-1/A
07/14/2025
7:31 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/14/2025
3:45 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/06/2025
8:22 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-K/A
01/07/2025
8:10 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
7:30 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:10 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:00 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/16/2024
4:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mayersohn Joel David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:06 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:06 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:07 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:07 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:08 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:09 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:09 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:08 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Hudson Bay Capital Management LP (Filed by)
Form SC 13G/A
09/13/2024
7:30 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:15 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
8:23 AM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
WOLVERINE ASSET MANAGEMENT LLC (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CTOR) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...
InvestorPlace | Sponsoredtc pixel
How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...
Brownstone Research | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel
Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...
Banyan Hill Publishing | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...
True Market Insiders | Sponsoredtc pixel